Progyny (NASDAQ: PGNY) reported Q1 EPS of $0.39, $0.26 better than the analyst estimate of $0.13. Revenue for the quarter came in at $278.1 million versus the consensus estimate of $289.43 million.

GUIDANCE:

Progyny sees Q2 2024 EPS of $0.39-$0.41, versus the consensus of $0.18. Progyny sees Q2 2024 revenue of $300-310 million, versus the consensus of $336 million.

Progyny sees FY2024 EPS of $1.61-$1.68, versus the consensus of $0.69. Progyny sees FY2024 revenue of $1.23-1.27 billion, versus the consensus of $1.3 billion.

For earnings history and earnings-related data on Progyny (PGNY) click here.